Skip to main content

Study

Alpha-Lipoic Acid and Vitamin B Complex May Ease Carpal Tunnel Pain

Taking alpha-lipoic acid with vitamin B complex showed potential in reducing pain from carpal tunnel syndrome.

Joint HealthPain ManagementExercise & Movement
Study Credibility: High8.0/10From a trusted journalProperly designed studyResults verified
PublishedDec 2025JournalBMC neurologyLast reviewedMar 2026
Email this

Summary

In plain language

Recent research suggests that an oral combination of alpha-lipoic acid and vitamin B complex could help alleviate pain for those with mild to moderate carpal tunnel syndrome (CTS). In a study involving 70 participants, those who took this supplement reported a significant decrease in pain compared to those who received a placebo. Although improvements in other areas like quality of life were noted, they weren't statistically significant. The supplement was generally well tolerated, with only mild side effects like stomach discomfort reported. This finding is promising for seniors seeking non-invasive methods to manage CTS pain, and further studies could confirm these benefits.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

The study was a well-structured trial involving 70 participants with mild to moderate CTS. It compared the effects of a daily dose of alpha-lipoic acid and vitamin B against a placebo over six months.

  • Participants who took the supplement showed some nerve function improvement, particularly in nerve action potential, but results were comparable to the placebo group.

  • The study was limited by its small size and short duration, emphasizing the need for further research.

  • For seniors, this suggests an alternative treatment with potential benefits and few side effects, but it's important to weigh options with a doctor.

Before starting any new treatment, consult your healthcare provider to see if it's right for you.

Research Quality Score

Scored March 8, 2026 using rubric v6_2026-02-01.

Assessment

The study is methodologically strong, being a double-blind, placebo-controlled RCT, which is a high level of evidence. It effectively controls for bias and is transparent in its reporting. However, the sample size is relatively small, and the study does not specifically focus on the senior population, which limits its direct applicability to adults aged 60+.

Category Breakdown

CategoryScoreRating
Study design9.0/10
Bias control9.0/10
Statistical methods8.0/10
Reporting completeness9.0/10
Conflicts & funding8.0/10
Replication6.0/10
Relevance to chosen population5.0/10
Journal Reliability8.0/10

Additional Notes

Future studies should consider larger sample sizes and include subgroup analyses for older adults to enhance relevance to the senior population.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.